Latest Information Update: 12 Sep 2008
At a glance
- Originator Japan Tobacco
- Mechanism of Action Diacylglycerol O acyltransferase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Obesity
Most Recent Events
- 30 Jun 2008 Discontinued - Phase-I for Obesity (PO)
- 09 Aug 2007 Phase-I clinical trials in Obesity (PO)